21216 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen; Proteins Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Formulations which stabilize and inhibit precipitation of immunogenic compositions
#902Compositions that include hemagglutinin
#903Cat dander allergen treatments
#904Multivalent pneumococcal polysaccharide-protein conjugate composition
#905Compositions that include hemagglutinin, methods of making and methods of use thereof
#906Methods and compositions for exotoxins
#907Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women
#908Mucosal meningococcal vaccines
#909Multivalent pneumococcal polysaccharide-protein conjugate composition
#910Multivalent pneumococcal polysaccharide-protein conjugate composition
#911Chimeric peptide immunogens
#912Method of immunizing humans against using a Vi-EPA conjugate vaccine
#913Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
#914Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
#915Glucan-based vaccines
#916Polysaccharide-protein conjugate vaccines
#917Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein
#918Process for preparing polysaccharide-protein conjugate vaccines
#919Injectable vaccines against multiple meningococcal serogroups
#920Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
#921Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
#922Conjugate vaccines for the prevention of dental caries
#923Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
#924Immunogenic capsule composition for use as a vaccine component against
#925Process for producing a capsular polysaccharide for use in conjugate vaccines
#926NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#927Vaccines against group neisseria meningitidis and meningococcal combinations thereof
#928Carrier proteins for vaccines
#929Polysaccharide derivatives and uses in induction of an immune response
#930Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#931Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#932Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#933Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#934Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#935Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#936Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#937Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#938Transgenic plant-based vaccines
#939Modulation of cholesteryl ester transfer protein (CETP) activity
#940Methods and compositions to enhance immune responses via recall antigens
#941Methods and compositions for impairing multiplication of HIV-1
#942Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
#943Hetero type pentamer recombinant vaccine
#944Immunomodulatory constructs and their uses
#945Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#946Multivalent pneumococcal polysaccharide-protein conjugate composition
#947Compositions and methods for enhancing the immunogenicity of antigens
#948Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof
#949Cholesterol-containing compounds and their use as immunogens against
#950Combinations of growth-and hormone-regulating factors for the treatment of neoplasia
#951Glycoconjugate vaccines for use in immune-compromised populations
#952Polysaccharide and glycoconjugate vaccines
#953Cross-protective epitopes of moraxella catarrhalis and use thereof
#954Mucosal combination vaccines for bacterial meningitis
#955Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use
#956Intranasal delivery of pneumococcal polysaccharide vaccines
#957Combination treatment of pancreatic cancer
#958Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
#959Modified streptococcal polysaccharides and uses thereof
#960Polyanionic polymer adjuvants for haemophilus influenzae B saccharide vaccines
#961Vaccine comprising il-13 and an adjuvant
#962Vaccine
#963Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
#964Methods and compositions for promoting immunopotentiation
#965DNA vaccines that expresses mutant ADP-ribosyItransferase toxins which display reduced, or are devoid of, ADP-ribosyltransferase activity
#966Intranasal immunization with detoxified lipooligosaccharide from nontypeable or
#967Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#968Mucosal vaccines with chitosan adjuvant and meningococcal antigens
#969Method for the treatment of gastroesophageal reflux disease
#970Prevention and treatment of amyloidogenic disease
#971Prevention and treatment of amyloidogenic disease
#972Immunogenic LHRH compositions and methods relating thereto
#973Nucleic acid adjuvants
#974Composition and method for enhancing immune response
#975Vaccine
#976GM1 binding deficient exotoxins for use as immunoadjuvants
#977Mutant forms of EtxB and CtxB and their use as carriers
#978Treatment methods for eotaxin mediated inflammatory conditons
#979Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens
#980Methods for preparing immunogenic conjugates
#981Targeting of genetic vaccine vectors
#982Prevention and treatment of amyloidogenic disease
#983Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method
#984Prevention and treatment of amyloidogenic disease
#985Humanized antibodies that recognize beta amyloid peptide
#986Methods and compositions for impairing multiplication of HIV-1
#987Vectors for molecule delivery to CD11b expressing cells
#988Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
#989Mucosal cytotoxic T lymphocyte responses
#990Methods of delivery of exogenous proteins to the cytosol and uses thereof
#991Vaccine
#992Glucan-based vaccines
#993Vaccines
#994Prevention and treatment of amyloidogenic disease
#995Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products
#996Prevention and treatment of amyloidogenic disease
#997Prevention and treatment of amyloidogenic disease
#998Hiv vaccine and method of use
#999Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with Porphyromonas gingivalis
#1000Adjuvant activities of mutants of LT-IIa and LT-IIb enterotoxin lacking binding to ganglioside
#1001Group A streptococcal polysaccharide immunogenic compositions and methods
#1002Prevention and treatment of amyloidogenic disease
#1003Novel method for down-regulation of amyloid
#1004Vaccines against O157 infection
#1005Vaccines against O157 infection
#1006Prevention and treatment of amyloidogenic disease
#1007Hapten-carrier conjugates for treating and preventing nicotine addiction
#1008Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
#1009Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein
#1010Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#1011Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens
#1012Polysaccharide vaccine for staphylococcal infections
#1013antibodies
#1014Chimeric peptide immunogens
#1015Expression of protective antigens in transgenic chloroplasts
#1016Capsular polysaccharide solubilisation and combination vaccines
#1017Chimeric peptide immunogens
#1018Supression of allergic reactions by transdermal administration of allergens conjugated to cholera toxin or fragments thereof
#1019Process for preparing conjugate vaccines and the conjugate vaccines
#1020Compositions comprising antigens from serogroups B and C
#1021Modified immunogenic pneumolysin compositions as vaccines
#1022Prevention and treatment of amyloidogenic disease
#1023Prevention and treatment of amyloidogenic disease
#1024Prevention and treatment of amyloidogenic disease
#1025Prevention and treatment of amyloidogenic disease
#1026Prevention and treatment of amyloidogenic disease
#1027Vaccine
#1028Prevention and treatment of amyloidogenic disease
#1029Prevention and treatment of amyloidogenic disease
#1030Immunization method against Neisseria meningitidis serogroups A and C
#1031Prevention and treatment of amyloidogenic disease
#1032Prevention and treatment of amyloidogenic disease
#1033Prevention and treatment of amyloidogenic disease
#1034Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
#1035Method of enhanced immunogenicity to meningococcal vaccination
#1036Immunotherapeutic composition for prevention of obesity, nonalcoholic fatty liver disease and hypertriglyceridemia, and methods of use and preparation thereof
#1037Shiga toxin a subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation